SCHEMBL83145

SCHEMBL83145

CCC(CC)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22821854 0.86
SCHEMBL31648232 0.85
SCHEMBL798845 0.83
SCHEMBL18499293 0.81
SCHEMBL21157337 0.81
SCHEMBL23902179 0.81 ALDH1A1 (0.32)
SCHEMBL18077921 0.81
SCHEMBL24379479 0.81
SCHEMBL23544634 0.81
SCHEMBL19669575 0.81 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109866-A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2024-04-04 US claimed
EP-3802500-A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2021-04-14 EP claimed
US-10562884-B2 Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2020-02-18 US claimed
EP-2705049-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2016-10-19 EP claimed
US-8957203-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2015-02-17 US claimed
EP-2705049-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2014-03-12 EP claimed
WO-2012151195-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-11-08 WO claimed
EP-0897385-A1 HERBICIDAL HETEROCYCLICALLY ANNULATED BENZOYLISOTHIAZOLES BASF AKTIENGESELLSCHAFT (DE) 1999-02-24 EP claimed
EP-0897384-A1 HERBICIDAL BENZOYLISOTHIAZOLES BASF AKTIENGESELLSCHAFT (DE) 1999-02-24 EP claimed
WO-1997038987-A1 HERBICIDAL BENZOYLISOTHIAZOLES BASF AKTIENGESELLSCHAFT (DE) 1997-10-23 WO claimed
WO-1997038988-A1 HERBICIDAL HETEROCYCLICALLY ANNULATED BENZOYLISOTHIAZOLES BASF AKTIENGESELLSCHAFT (DE) 1997-10-23 WO claimed
EP-4400518-A1 ANTIGEN-TARGETING, ANTI-CD16A AND IMMUNE EFFECTOR CELL-ACTIVATING TRIFUNCTIONAL FUSION PROTEIN, AND USE THEREOF Qure Biotechnology (Shanghai) Co., Ltd. (CN) 2024-07-17 EP disclosed
US-20240209013-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-06-27 US disclosed
US-20240109866-A1 MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2024-04-04 US disclosed
WO-2024034522-A1 ADDITIVE FOR NON-AQUEOUS ELECTROLYTIC SOLUTION, NON-AQUEOUS ELECTROLYTIC SOLUTION, AND POWER STORAGE DEVICE 住友精化株式会社 2024-02-15 WO disclosed
EP-1622879-A1 PYRIMIDINE COMPOUNDS AND PESTS CONTROLLING COMPOSITION CONTAINING THE SAME Sumitomo Chemical Company, Limited (JP) 2006-02-08 EP disclosed
WO-2005037805-A2 1,2,4-THIADIAZOLE COMPOUNDS AND PESTS CONTROLLING COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2005-04-28 WO disclosed
WO-2004099160-A1 PYRIMIDINE COMPOUNDS AND PESTS CONTROLLING COMPOSITION CONTAINING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-18 WO disclosed
EP-0406748-B1 Dehydrofluorination and dehydrogenation of fluorinated alkanes ATOCHEM NORTH AMERICA (US) 1994-09-28 EP disclosed
EP-0406748-A2 Dehydrofluorination and dehydrogenation of fluorinated alkanes ATOCHEM NORTH AMERICA, INC. (US) 1991-01-09 EP disclosed